Gun Ei Chemical Industry (4229) Q4 2026 earnings summary
Event summary combining transcript, slides, and related documents.
Q4 2026 earnings summary
14 Oct, 2026Executive summary
FY Mar. 2026 revenue rose 2.5% YoY to ¥31,307 million; operating income increased 12.0% to ¥2,567 million.
Ordinary income rose 9.0% to ¥2,959 million; net income attributable to owners of the parent increased 2.8% to ¥1,973 million.
Comprehensive income surged 163.5% YoY to ¥5,876 million, driven by gains on available-for-sale securities.
Financial highlights
Gross profit increased to ¥7,064 million from ¥6,525 million; operating-income bridge included ¥760 million from sales factors, offset by ¥220 million in higher cost of sales and ¥260 million in higher SG&A.
Total assets were ¥68,012 million, up from ¥63,018 million; net assets reached ¥56,853 million.
Cash and cash equivalents at period end were ¥10,681 million, up from ¥9,536 million.
Outlook and guidance
FY Mar. 2027 earnings forecast is undecided amid Middle East uncertainty affecting raw-material pricing and procurement; guidance will be announced when a reasonable calculation is possible.
FY Mar. 2027 dividend is undecided pending a reasonable earnings forecast.
Latest events from Gun Ei Chemical Industry
- Profit surged in H1 as pricing and environmental materials offset weak electronics demand.4229
Q2 2024 - Profit rebounded sharply, but FY25 guidance anticipates margin pressure amid major capacity investment.4229
Q4 2024 - Sales and operating profit rose sharply, but net profit fell on extraordinary losses.4229
Q1 2027 - Quarterly sales and profits declined year-over-year, with lower full-year profit guidance.4229
Q1 2025 - Sales and profits fell year-over-year, with profit margins under pressure despite strong equity.4229
Q3 2025 - H1 earnings fell, but semiconductor strength lifted profit guidance as the sales outlook was cut.4229
Q2 2025 - Sales rose, operating profit fell, and FY2031 targets include ¥40 billion operating profit.4229
Q4 2025 - Sales rose slightly, but profits declined; full-year outlook expects lower earnings.4229
Q1 2026 - H1 sales and operating profit rose, while net profit edged lower and FY guidance held.4229
Q2 2026